MORTALITY FROM THE 1ST GENERATION ANTIHISTAMINE MEDICATIONS. POLICY OF THE REGULATORS. POSITION OF A PEDIATRICIAN
.
Saved in:
| Main Author: | L.S. Namazova-Baranova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2009-06-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/917 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ALLERGY AND ANTIHISTAMINIC MEDICATIONS
by: R.M. Torshkhoeva
Published: (2008-05-01) -
90TH ANNIVERSARY OF THE UNION OF PEDIATRICIANS OF RUSSIA
by: V. Yu. Al’bitsky, et al.
Published: (2017-02-01) -
ANTIHISTAMINE MEDICATIONS: EFFICACY AND SAFETY OF USING IN PEDIATRIC PRACTICE
by: L.R. Giniyatova, et al.
Published: (2010-05-01) -
IMPACT OF THE SECOND GENERATION ANTIHISTAMINES ON COGNITIVE FUNCTION IN CHILDREN WITH POLLEN ALLERGY RECEIVING SPECIFIC ALLERGEN IMMUNOTHERAPY
by: O. I. Muradova, et al.
Published: (2015-04-01) -
ANTIHISTAMINES IN PEDIATRIC PRACTICE
by: article Editorial
Published: (2021-01-01)